The upside case is real because POET now has funding, partner validation, and a product set aimed at a fast-growing
AI optics layer. The catch is that the stock is no longer priced like a forgotten micro-cap. A strong outcome needs commercial proof, not just more demos. If POET becomes a repeat supplier for
optical engines and light sources and adds some higher-quality IP or contract revenue, a multi-year
re-rating is plausible, but not a carefree one.